165 related articles for article (PubMed ID: 32180472)
1. Correlation between antibiotic use in childhood and subsequent inflammatory bowel disease: a systematic review and meta-analysis.
Zou Y; Wu L; Xu W; Zhou X; Ye K; Xiong H; Song C; Xie Y
Scand J Gastroenterol; 2020 Mar; 55(3):301-311. PubMed ID: 32180472
[No Abstract] [Full Text] [Related]
2. Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis.
Ungaro R; Bernstein CN; Gearry R; Hviid A; Kolho KL; Kronman MP; Shaw S; Van Kruiningen H; Colombel JF; Atreja A
Am J Gastroenterol; 2014 Nov; 109(11):1728-38. PubMed ID: 25223575
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic Use in Childhood and Adolescence and Risk of Inflammatory Bowel Disease: A Case-Control Study in the UK Clinical Practice Research Datalink.
Troelsen FS; Jick S
Inflamm Bowel Dis; 2020 Feb; 26(3):440-447. PubMed ID: 31265060
[TBL] [Abstract][Full Text] [Related]
4. The association of antibiotic exposure with new-onset inflammatory bowel disease: A systematic review and meta-analysis.
Dar SH; Maniya MT; Merza N; Musheer A; Zahid M; Ahmed F; Shurjeel Q; Qazi S; Ahmed A; Shah H; Zafar A; Iqbal AZ; Khan SF; Rizwan T; Ligresti R
Clin Res Hepatol Gastroenterol; 2023 May; 47(6):102129. PubMed ID: 37116651
[TBL] [Abstract][Full Text] [Related]
5. Urban-rural environmental exposure during childhood and subsequent risk of inflammatory bowel disease: a meta-analysis.
Song C; Yang J; Ye W; Zhang Y; Tang C; Li X; Zhou X; Xie Y
Expert Rev Gastroenterol Hepatol; 2019 Jun; 13(6):591-602. PubMed ID: 30101634
[TBL] [Abstract][Full Text] [Related]
6. The risk of antibiotics and enterocolitis for the development of inflammatory bowel disease: a Japanese administrative database analysis.
Shimodaira Y; Watanabe K; Iijima K
Sci Rep; 2022 May; 12(1):7604. PubMed ID: 35534662
[TBL] [Abstract][Full Text] [Related]
7. Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease--a nationwide, register-based finnish case-control study.
Virta L; Auvinen A; Helenius H; Huovinen P; Kolho KL
Am J Epidemiol; 2012 Apr; 175(8):775-84. PubMed ID: 22366379
[TBL] [Abstract][Full Text] [Related]
8. Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn's disease and ulcerative colitis exacerbation.
Moninuola OO; Milligan W; Lochhead P; Khalili H
Aliment Pharmacol Ther; 2018 Jun; 47(11):1428-1439. PubMed ID: 29620794
[TBL] [Abstract][Full Text] [Related]
9. Association between spring season of birth and Crohn's disease.
Shaw SY; Nugent Z; Targownik LE; Singh H; Blanchard JF; Bernstein CN
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):277-82. PubMed ID: 23924874
[TBL] [Abstract][Full Text] [Related]
10. Antibiotics exposure and risk of inflammatory bowel disease: a systematic review.
Theochari NA; Stefanopoulos A; Mylonas KS; Economopoulos KP
Scand J Gastroenterol; 2018 Jan; 53(1):1-7. PubMed ID: 29022402
[TBL] [Abstract][Full Text] [Related]
11. Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis.
Shaw SY; Blanchard JF; Bernstein CN
Am J Gastroenterol; 2011 Dec; 106(12):2133-42. PubMed ID: 21912437
[TBL] [Abstract][Full Text] [Related]
12. Consumption of vegetables and fruit and the risk of inflammatory bowel disease: a meta-analysis.
Li F; Liu X; Wang W; Zhang D
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):623-30. PubMed ID: 25831134
[TBL] [Abstract][Full Text] [Related]
13. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
14. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
Ng SC; Shi HY; Hamidi N; Underwood FE; Tang W; Benchimol EI; Panaccione R; Ghosh S; Wu JCY; Chan FKL; Sung JJY; Kaplan GG
Lancet; 2017 Dec; 390(10114):2769-2778. PubMed ID: 29050646
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease.
Korzenik J; Larsen MD; Nielsen J; Kjeldsen J; Nørgård BM
Aliment Pharmacol Ther; 2019 Aug; 50(3):289-294. PubMed ID: 31267570
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease.
Godet PG; May GR; Sutherland LR
Gut; 1995 Nov; 37(5):668-73. PubMed ID: 8549943
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics for induction and maintenance of remission in Crohn's disease.
Townsend CM; Parker CE; MacDonald JK; Nguyen TM; Jairath V; Feagan BG; Khanna R
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012730. PubMed ID: 30731030
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.
Khan KJ; Ullman TA; Ford AC; Abreu MT; Abadir A; Marshall JK; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):661-73. PubMed ID: 21407187
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic use and inflammatory bowel diseases in childhood.
Hviid A; Svanström H; Frisch M
Gut; 2011 Jan; 60(1):49-54. PubMed ID: 20966024
[TBL] [Abstract][Full Text] [Related]
20. Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data.
Etminan M; Bird ST; Delaney JA; Bressler B; Brophy JM
JAMA Dermatol; 2013 Feb; 149(2):216-20. PubMed ID: 23426479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
